Results 41 to 50 of about 8,510,672 (246)

MagmaFlow: A desktop platform for artificial intelligence‐driven expression analysis

open access: yesFEBS Open Bio, EarlyView.
MagmaFlow is a free, no‐code platform for gene expression analysis. It generates interactive volcano plots, links genes to literature, pathways, and diseases, prioritizes candidates using millions of publications, identifies affected biological processes, builds network diagrams, and exports publication‐ready figures and reports for macOS and Windows ...
Carlos E. Buss   +7 more
wiley   +1 more source

[McCormick & Company loading dock]

open access: yes, 1905
From Sleeve: #1647. McCormick & Company. Loading Dock.Title supplied by cataloger.Positive digital file from original glass negativeEmulsion deteriorating along the ...
Hughes Company
core   +1 more source

[Mack International Truck Company]

open access: yes, 1923
From Sleeve: #1486. Mack International Truck Company. 1923. (24051).Title supplied by cataloger.Positive digital file from original glass negativeEmulsion wearing away on the right side of the ...
Hughes Company
core   +1 more source

Weather Regimes of Extreme Wind Speed Events in Xinjiang: A 10–30 Year Return Period Analysis

open access: yesAtmosphere
Xinjiang is a critical wind energy region in China. This study characterizes extreme wind speed (EWS) events in Xinjiang by using ERA5 reanalysis (1979–2023) and station observations (2022–2023).
Yajie Li   +7 more
doaj   +1 more source

Using cell‐free RNA to identify B‐ and T‐cell clonality for diagnosis and monitoring of B‐ and T‐cell neoplasms

open access: yesFEBS Open Bio, EarlyView.
Using peripheral blood for determining B‐cell or T‐cell clonality is more reliable when we use cell‐free RNA (cfRNA) because cells release blood significantly more RNA than DNA. Next‐generation sequencing (NGS) of cfRNA allows us to evaluate fragment cfRNA and evaluate clonality reliably without the need for prior determination of the specific dominant
Adam Albitar   +11 more
wiley   +1 more source

Self‐Regulated Learning Meets AI: Reinterpreting Self‐Regulation, Co‐Regulation, and Socially Shared Regulation in Human–AI Interaction

open access: yesNew Directions for Adult and Continuing Education, EarlyView.
ABSTRACT Advancing artificial intelligence (AI) has transformed learning and work, yet higher education and professional development programs have not systematically equipped learners for AI‐prevalent environments. This lack of preparation creates uncertainty regarding control, responsibility, trust, and accountability.
Moon‐Heum Cho, Jerusalem Merkebu
wiley   +1 more source

Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
Multiple Sclerosis Relapse Activity After Ozanimod Discontinuation in DAYBREAK Trial Participants. ABSTRACT Objective Return of disease activity is expected when patients discontinue disease‐modifying therapy (DMT) for multiple sclerosis (MS). Some MS DMTs are associated with higher‐than‐expected disease activity (rebound) after discontinuation.
Ralf Gold   +12 more
wiley   +1 more source

[Otis Elevator Company stockroom]

open access: yes, 1924
From sleeve: View of Otis Elevator Company Stockroom. 1924-06Title supplied by cataloger.Positive digital file from original glass negativeSevere Emulsion Peeling ...
Hughes Company
core   +1 more source

[Thompson Manufacturing Company building]

open access: yes, 1923
From Sleeve: Exterior as Schultz Block. Location of Thompson Manufacturing Company. 1923. A304.Thompson Manufacturing, maker of toys, 2220 Boston, BaltimoreTitle supplied by cataloger.Positive digital file from original glass negative.Chips in emulsion ...
Hughes Company
core   +1 more source

GAD65 Antibody ELISA With Extended Reportable Range: Validation and Guidance for Neurological Practice

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To (1) validate GAD65‐ELISA detection and quantification for type 1 diabetes mellitus and autoimmune neurological diagnoses, (2) correlate ELISA results (reference range < 5 IU/mL) with established radioimmunoprecipitation assay (RIA; ≤ 0.02 nmol/L), and (3) define ELISA clinical utility and pitfalls.
Andrew McKeon   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy